Esomeprazole Sodium is Used for short-term treatment of gastroesophageal reflux disease (GERD) when oral therapy with Nexium capsules is not possible or appropriate. It was first introduced by Astrazeneca Pharmaceuticals Lp in its drug Nexium Iv on Mar 31, 2005. 9 different companies have introduced drugs containing Esomeprazole Sodium.

Esomeprazole Sodium Patents

Given below is the list of patents protecting Esomeprazole Sodium, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Nexium Iv	US5877192 (Pediatric)	Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole	Nov 27, 2014 (Expired)	Astrazeneca
Nexium Iv	US5877192	Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole	May 27, 2014 (Expired)	Astrazeneca
Nexium Iv	US6143771	Compounds	May 27, 2014 (Expired)	Astrazeneca

Add above patents to watchlist

Esomeprazole Sodium's Family Patents

Full family tree

Esomeprazole Sodium Generic API Manufacturers

Several generic applications have been filed for Esomeprazole Sodium. The first generic version for Esomeprazole Sodium was by Sun Pharmaceutical Industries Ltd and was approved on Mar 18, 2013. And the latest generic version is by Epic Pharma Llc and was approved on Jan 8, 2025.

Given below is the list of companies who have filed for Esomeprazole Sodium generic, along with the locations of their manufacturing plants worldwide.